The Urological Cancer Charity (UCAN) based in northern Scotland has managed to raise £2.8m which will allow them to buy robot-assisted surgical technology to be used in hospitals in Aberdeen. Much of this is due to a Scottish government investment of £1m.
This new technology is set to be used from 2015 in two new state-of-the-art theatres at the Aberdeen Royal Infirmary. The robot technology will be utilised to treat the most common cancer in men, prostate cancer.
This type of surgery significantly reduces the risk of complications by eliminating open surgery with a minimally invasive procedure which offers greater access to the abdomen and the chest, without having to make large incisions into the body of the patient.
The robotic system, known as da Vinci, was first introduced during 1999, by the American company named Intuitive Surgical. One of the robots has already been available at Guy’s and St Thomas’ hospital in London.
The US Food and Drug Administration (FDA), this year approved the latest model of the robot, da Vinci XI, for use in hospitals in America. It has four arms with an endoscope that is able to be attached to any of the arms, along with a new high-definition 3D vision system which allows surgeons to view a magnified version of the area they are operating on.
The chairman of UCAN and a consultant urological surgeon, Professor Sam McClinton, was very pleased with the news and offered his thanks to the Scottish Government for their help in bringing this technology to Aberdeen Royal Infirmary.
He said that the organisation would also like to give thanks to everyone who supported the Robotic Surgery for North Scotland campaign, including those who offered donations, as well as NHS Grampian and its endowment fund who offered huge support.
Image Credit: ImadCode